We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Updated: 12/31/1969
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Status: Enrolling
Updated: 12/31/1969
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Updated: 12/31/1969
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS
Updated: 12/31/1969
Safety and Tolerability of Serum-Derived Bovine Immunoglobulin in Children With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS
Updated: 12/31/1969
Safety and Tolerability of Serum-Derived Bovine Immunoglobulin in Children With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
Updated: 12/31/1969
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
Updated: 12/31/1969
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Personalized Vitamin D Supplementation in European and African Americans
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Status: Enrolling
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Personalized Vitamin D Supplementation in European and African Americans
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Status: Enrolling
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Updated: 12/31/1969
Personalized Vitamin D Supplementation in European and African Americans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Updated: 12/31/1969
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Updated: 12/31/1969
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Updated: 12/31/1969
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Updated: 12/31/1969
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fatty Liver Study in Patients With Type II Diabetes
Updated: 12/31/1969
A Phase IV, Open Label, Randomized Trial on the Effect of Metformin Plus Lantus Insulin, Pioglitazone, or DPP4 Inhibitor on Fatty Liver in Patients With Type II Diabetes
Status: Enrolling
Updated: 12/31/1969
Fatty Liver Study in Patients With Type II Diabetes
Updated: 12/31/1969
A Phase IV, Open Label, Randomized Trial on the Effect of Metformin Plus Lantus Insulin, Pioglitazone, or DPP4 Inhibitor on Fatty Liver in Patients With Type II Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
Updated: 12/31/1969
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
Updated: 12/31/1969
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
Updated: 12/31/1969
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
Updated: 12/31/1969
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Motilitone to Treat Functional Dyspepsia
Updated: 12/31/1969
Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia
Status: Enrolling
Updated: 12/31/1969
Study of Motilitone to Treat Functional Dyspepsia
Updated: 12/31/1969
Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy of Ear Neurostimulation for Adolescents With Functional Abdominal Pain
Updated: 12/31/1969
Efficacy of Auricular Neurostimulation for Adolescents With Pain-Associated Functional Gastrointestinal Disorders
Status: Enrolling
Updated: 12/31/1969
Efficacy of Ear Neurostimulation for Adolescents With Functional Abdominal Pain
Updated: 12/31/1969
Efficacy of Auricular Neurostimulation for Adolescents With Pain-Associated Functional Gastrointestinal Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Shear Wave Sonoelastography in Pediatric Liver Fibrosis
Updated: 12/31/1969
Shear Wave Sonoelastography for the Noninvasive Evaluation of Hepatic Fibrosis in the Pediatric Population
Status: Enrolling
Updated: 12/31/1969
Shear Wave Sonoelastography in Pediatric Liver Fibrosis
Updated: 12/31/1969
Shear Wave Sonoelastography for the Noninvasive Evaluation of Hepatic Fibrosis in the Pediatric Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mesenchymal Stem Cell and Islet Co-transplantation
Updated: 12/31/1969
A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow-derived Mesenchymal Stromal Cells in Chronic Pancreatitis Patients Who Undergo Total Pancreatectomy and Islet Autotransplantation.
Status: Enrolling
Updated: 12/31/1969
Mesenchymal Stem Cell and Islet Co-transplantation
Updated: 12/31/1969
A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow-derived Mesenchymal Stromal Cells in Chronic Pancreatitis Patients Who Undergo Total Pancreatectomy and Islet Autotransplantation.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octaplas Pediatric Plasma Replacement Trial
Updated: 12/31/1969
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Updated: 12/31/1969
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials